Meet Our Scientific Advisory Board

Our Scientific Advisory Board brings decades of experience in dermatology, skin cancer, genomics, and biotech innovation to help us redefine the way we test and treat skin cancer.

Lisa Beck, M.D.

Dr. Beck brings more than 20 years’ experience to the treatment of atopic dermatitis and eczema. She received her undergraduate degree from Mount Holyoke College and her medical degree from the State University of New York at Stony Brook. She completed her dermatology residency at Duke University and an Immunology Research fellowship at Johns Hopkins University. Dr. Beck is Co-Director of the URMC Center for Allergic Disease Research (CADR), one of four US centers with the World Allergy Organizations Center of Excellence designation. She has been the secretary of the International Eczema Council (IEC) since its inception in 2014, emeritus member of the National Eczema Association (NEA) Scientific Advisory committee, and is currently President-Elect of the Society of Investigative Dermatology.

Klaus Busam, M.D.

Klaus Busam, M.D., is a dual board-certified pathologist specializing in melanoma and other skin cancers holding a wealth of expertise in a variety of inflammatory reactions, including eczema and graft versus host disease. He is also an expert in cutaneous reactions to novel therapeutic agents, both targeted and immunomodulatory. Dr. Busam is currently the director of dermatology and immunohistochemistry at Memorial Sloan Kettering Cancer Center and directs the center’s joint dermatopathology training program with Cornell University. He received his medical degree at the University of Freiburg and completed Harvard Medical School’s dermatopathology fellowship prior to his residency at the Brigham’s and Women’s Hospital and Children’s Hospital at Harvard Medical School.

Laura Ferris, M.D., Ph.D.

Laura Korb Ferris, M.D., Ph.D., is a Professor and Director of Clinical Trials at the University of Pittsburgh Department of Dermatology. She is a member of the University of Pittsburgh Cancer Institute melanoma program, where she directs the pigmented lesions clinic. Dr. Ferris has been an investigator on several clinical trials evaluating technologies and assays for melanoma early detection and predictors of outcome in patients with melanoma. Her research, which is primarily focused on melanoma epidemiology, screening, and early detection has been widely published in the peer-reviewed literature. Dr. Ferris received her Ph.D. in immunology from The Johns Hopkins School of Medicine and her M.D. from The University of Maryland and she completed her residency in dermatology and fellowship in cutaneous oncology at the University of Pittsburgh.

George Han, M.D., Ph.D.

Dr. Han currently serves as the System Medical Director for Dermatology and Chief of Teledermatology at the Mount Sinai Health System. Dr. Han is the current Vice President of the Dermatologic Society of Greater New York and a member of the Medical Board of the National Psoriasis Foundation. To date, Dr. Han has over 50 publications in well-respected journals such as the Journal of the American Academy of Dermatology, the Journal of Investigative Dermatology, the Journal of Infectious Diseases, the British Journal of Dermatology, and the American Journal of Pathology. He remains active in both basic science research and clinical trials.

Ronald Moy, M.D.

Dr. Ronald Moy is a board-certified dermatologist and a diplomate of the American Board of Dermatology. He is a leader in the field of dermatology as a past President of the American Academy of Dermatology, Pacific Dermatologic Association and American Society for Dermatologic Surgery and as Vice President of the Skin Cancer Foundation. Dr. Moy completed his dermatology residency training at UCLA and his Facial Cosmetic and Mohs Micrographic Surgery Fellowship training at the University of Pittsburgh Center for Health Services. He is a former professor at the David Geffen School of Medicine at UCLA, former Co-Chief of the UCLA division of Dermatology and former Chief of Dermatologic Surgery. He has served as president of the Los Angeles County Medical Association, Bay District and Editor-in-Chief of the Dermatologic Surgery Journal.

Joslyn Kirby, M.D., M.P.H.

Joslyn Kirby, M.D., M.P.H., currently serves as associate professor of dermatology, director of the Dermatology Residency Program and vice chair of education at Pennsylvania State University. In her clinical and research work, she is interested in acneiform conditions including rosacea and hidradenitis suppurativa and is a board member of the Hidradenitis Suppurativa Foundation. She received her medical degree from the University of Virginia and completed her dermatology residency at the University of Pennsylvania. Dr. Kirby also completed her master’s degree in public health sciences and adult education from Pennsylvania State University.

Daniel Siegel, M.D.

Dr. Daniel M. Siegel is a Clinical Professor of Dermatology and former Director of the Procedural Dermatology Fellowship at SUNY Downstate. He has served as president of the AAD (2012) and is a past member of both the Academy’s Board of Directors and Coding and Reimbursement Task Force. He is a diplomate of the American Board of Dermatology and the American Board of Laser Surgery and is a fellow of the American Society for Dermatologic Surgery (ASDS), the American Academy of Dermatology (AAD), the American College of Mohs Surgery and the American Society of Mohs Surgery. Dr. Siegel earned his medical degree from Albany Medical College in Albany, NY. He completed his residency in dermatology at the University of Texas Health Sciences Center at Dallas and his fellowship at the Baylor College of Medicine in Houston. Dr. Siegel also earned a Master of Science degree in management and policy from Stony Brook University in Stony Brook, NY.